当前位置: 易推广 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > MedChemExpress > 产品展示 > MCE信号通路 > 神经信号通路 > Emrusolmin
Emrusolmin
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:8年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:91228
参观次数:11317701
联系我们
MedChemExpress
电话:021-58955995
联系人:客服部 (请说明是在易推广看到的!谢谢)
手机:13611715263
邮编:201203
邮箱:sales@medchemexpress.cn
地址:上海上海
详细内容
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Emrusolmin
CAS No. : 882697-00-9
MCE 站:Emrusolmin
产品活性:Emrusolmin (Anle138b) 是一种低聚物聚集抑 (oligomeric aggregation ) 调节剂,可阻断朊病毒蛋白 (PrPSc) 和 α-突触核蛋白 (α-syn) 病理性聚集的形成。Emrusolmin 在体内强烈抑制低聚物积累、神经元变性和疾病进展。Emrusolmin 毒性低,口服生物利用度高,血脑屏障通透性好。Emrusolmin 阻断 Aβ 通道并挽救淀粉样变性小鼠模型的疾病表型。
研究领域:Neuronal Signaling
作用靶点:Amyloid-β
In Vitro: Oligomeric aggregates are presumed to be the key neurotoxic agent. Emrusolmin blocksthe formation of pathological aggregates of prion protein and of α-synuclein, which is deposited in Parkinson’s disease and other synucleinopathies such as dementia with Lewy bodies and multiple system atrophy. Emrusolmin strongly inhibits all prion strains tested including BSE-derived and human prions. Emrusolmin shows structure-dependent binding to pathological aggregates and strongly inhibits formation of pathological oligomers both for prion protein and α-synuclein.
In Vivo: Emrusolmin shows structure-dependent binding to pathological aggregates and strongly inhibits formation of pathological oligomers in vitro and in vivo both for prion protein and α-synuclein.
Emrusolmin (0.6-2 g/kg; p.o.) modulates αsynuclein oligomerization.
相关产品:Clinical Compound Library Plus | Bioactive Compound Library Plus | Neuronal Signaling Compound Library | Clinical Compound Library | CNS-Penetrant Compound Library | Orally Active Compound Library | Anti-Alzheimer's Disease Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Rare Diseases Drug Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | THK-523 | β-Amyloid (12-28) | NIAD-4 | MAO-B-IN-9 | Ginsenoside Rg1 | Fustin | β-Amyloid (33-40) | Lecanemab | Timosaponin BII | 20(S)-Ginsenoside Rg3 | β-Amyloid (1-19) (acetate) | Glimepiride-d4-1 | Direct Blue 1 | PBD-150 | Rutin hydrate | Fmoc-His(3-Me)-OH | β-Amyloid (1-43)(human) | SQ-3 | Saikosaponin C | Tolcapone-d7 | Glimepiride | Crocetin monomethyl ester | CRANAD-2 | Valiltramiprosate | Acetyl-Amyloid β-Protein (1-6) amide | β-Amyloid Protein Precursor 770 (135-155) | 2-O-Acetyl-20-hydroxyecdysone | FSB | AY1511 | Birtamimab
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿*全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
热门标签:Anle138b